Your trusted destination for CME, CPD & Medical Education across the Middle East.
PLASMA 2027 is a premier masterclass dedicated to advancing clinical excellence in the field of multiple myeloma. Bringing together leading international and regional experts, the event will explore the latest scientific breakthroughs, emerging therapies, and their practical applications in clinical care. Attendees will benefit from high-level discussions, expert-led sessions, and networking opportunities designed to elevate the standard of care for multiple myeloma patients.
Exploring the latest advancements and clinical outcomes of CAR T-cell therapies in myeloma patients.
Understanding the role and efficacy of bispecific antibodies in relapsed and refractory settings.
Reviewing new drug classes and targeted therapies currently in clinical trials.
Utilizing genomic data to risk-stratify patients and personalize treatment plans.
The prognostic value of MRD monitoring and its impact on treatment decisions.
Optimizing induction, consolidation, and maintenance therapies for newly diagnosed patients.
Evidence-based sequencing of therapies for patients with relapsed or refractory multiple myeloma.
Strategies for managing treatment-related toxicities and improving patient quality of life.
Secure your seat and earn full credit eligibility with encrypted checkout.
Secure payment processing & PCI-aligned flow